Benbassat J, Penchas S
Acta Haematol. 1981;65(3):189-92. doi: 10.1159/000207177.
The data available for 338 cases of splenectomy in agnogenic myeloid metaplasia published since 1940 were retrieved from the literature and analyzed. The median survival of cases operated upon at an early stage of the disease (as judged by their hemoglobin level, platelet number, and splenic size) was compared with the survival reported in conservatively treated patients diagnosed at an early stage of agnogenic myeloid metaplasia. Survival time since diagnosis of patients with early splenectomy was similar to, or shorter than, that reported in conservatively treated patients with early agnogenic myeloid metaplasia.
检索并分析了自1940年以来发表的关于338例原发性骨髓化生脾切除术的可用数据。将疾病早期接受手术治疗的患者（根据其血红蛋白水平、血小板数量和脾脏大小判断）的中位生存期与原发性骨髓化生早期诊断的保守治疗患者的生存期进行了比较。早期脾切除患者自诊断后的生存时间与原发性骨髓化生早期保守治疗患者的生存时间相似或更短。
